OTCA21 ‘Hypoglossal Nerve Stimulation (HGNS) for treatment of obstructive sleep apnea’ Final Assessment now available
EUnetHTA is pleased to announce that the OTCA21 Final Assessment is now available for access. The assessed technology is Hypoglossal Nerve Stimulation (HGNS) for treatment of obstructive sleep apnea. The aim of this assessment was to evaluate effectiveness and safety of HGNS compared with no treatment in those adult patients with moderate-to-severe obstructive sleep apnea […]
PTJA11 – Cefiderocol for the treatment of infections due to aerobic Gram-negative bacteria in adult patients with limited treatment options – Final assessment now available
This is the pharmaceutical Joint Assessment PTJA11 – Cefiderocol for the treatment of infections due to aerobic Gram-negative bacteria in adult patients with limited treatment options. In April 2020, the European Commission granted marketing authorisation for Fetcroja® (cefiderocol) for the treatment of infections due to aerobic Gram-negative bacteria in adult patients with limited treatment options. […]
Patient group input requested for a new EUnetHTA Assessment on surgical techniques and devices for the treatment of benign prostatic hyperplasia.
EUnetHTA deems patient involvement very important in the production of Joint/Collaborative Assessment reports. We recognise that patients and those who support them have unique knowledge about what it is like to live with a specific disease or medical condition. We believe patient groups can help us understand patients’ unique perspectives by collecting and presenting patients’ […]
The role of antibody tests for novel coronavirus SARS-CoV-2 in the management of the current pandemic – Final Project Plan now published
EUnetHTA is pleased to announce the publication of the final project plan of its Rapid Collaborative Review on the role of antibody tests for novel coronavirus SARS-CoV-2 in the management of the current pandemic. This is the first one of a series of Rapid Collaborative Reviews related to SARS-CoV-2 that EUnetHTA is planning to develop, and […]
Summary from December 2019 EUnetHTA-EFPIA Technical Meeting now available
The summary from the EUnetHTA-EFPIA Technical Meeting, held on 2 December 2019 at the Haute Autorité de Santé in Paris, is now available for access. Please find the summary at this link and on the EFPIA site.
EMA-EUnetHTA Bilateral Meeting – November 2019 – documentation now available
The minutes from the EMA-EUnetHTA Bilateral Meeting, hosted by EUnetHTA at the Zorginstituut Nederland (ZIN) in Diemen, Netherlands, on 21st November, 2019, are now available for access. Topics discussed included a follow-up on registries, patient-reported outcomes as part of evidence generation plans, PLEG, and more. In addition, a review on EMA-EUnetHTA activities in the context […]
Declaration of Confidentiality – FAQ now available
A list of Frequently Asked Questions on Declaration of Interest is now available to accompany and inform the confidentiality process. Follow the link for more information: https://www.eunethta.eu/doi/
EUnetHTA 2019 Forum Paper now available for access
We are happy to announce that our paper, ‘The fourth edition of the European Network for Health Technology Assessment: highlights and outcomes’, has been published this week on the International Journal of Technology Assessment in Health Care. The paper is available at this link: Thank you for your cooperation and congratulations to all those involved. Giovanni […]
Recommendations for Horizon Scanning, Topic Identification, Selection and Prioritisation for European Cooperation on Health Technology Assessment now available
The final report ‘Recommendations for Horizon Scanning, Topic Identification, Selection and Prioritisation for European Cooperation on Health Technology Assessment’ is now available. The draft recommendations were under consultation during the period July–September 2018. An overview and response to the feedback during the consultation is available, together with Endpoint Evaluations for both Pharmaceuticals and Other Technologies. […]
“Healthcare Professional Involvement in Relative Effectiveness Assessments” is now published and available for access
At the request of the EUnetHTA Executive Board, a cross-work package (WP) task group on the involvement of Health Care Providers (HCP) and Patients & Consumers (P&C) was established in Fall 2017. The task group includes representatives from WP1, WP2, WP4, and WP5. The task group is operational in nature and the scope is involvement […]
